Tumor Suppressor WWOX and p53 Alterations and Drug Resistance in Glioblastomas

Tumor suppressor p53 are frequently mutated in glioblastomas (GBMs) and appears to contribute, in part, to resistance to temozolomide (TMZ) and therapeutic drugs. WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptotic protein and is considered as a tumor suppressor. Loss of WWOX ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiang, Ming-Fu, Chou, Pei-Yi, Wang, Wan-Jen, Sze, Chun-I, Chang, Nan-Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586680/
https://www.ncbi.nlm.nih.gov/pubmed/23459853
http://dx.doi.org/10.3389/fonc.2013.00043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586680/
https://www.ncbi.nlm.nih.gov/pubmed/23459853
http://dx.doi.org/10.3389/fonc.2013.00043

Ejemplares similares